Amgen Inc. (AMGN) - Form 4 Filing Summary

This Form 4 filing details transactions by Mary E. Klotman, a director at Amgen Inc. On May 19, 2026, Ms. Klotman acquired 665 shares of Amgen's Common Stock under the Amgen Inc. 2009 Director Incentive Program. These shares were granted as Restricted Stock Units (RSUs) which vested immediately. The RSUs were paid in shares of common stock on a one-to-one basis. Ms. Klotman's post-transaction ownership stands at 2211 shares. The filing also notes the inclusion of 18 DEs subject to a dividend reinvestment plan, which are credited to her unvested RSUs and paid out according to the vesting schedule.